SCHEMBL26164166

SCHEMBL26164166

Cc1cccc(-c2ccccc2-c2cccc([N+](=O)[O-])c2F)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
TDP1 Q9NUW8 6/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 6/20 0.40
S100A4 P26447 2/20 0.40
PTPRC P08575 1/20 0.40
HSD11B1 P28845 1/20 0.38
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26167518 0.82 ALDH1A1 (0.54) SMN1; SMN2GAATDP1LMNAL3MBTL1
SCHEMBL29470932 0.82 ALDH1A1 (0.54) SMN1; SMN2GAATDP1LMNAL3MBTL1
SCHEMBL29565619 0.81 HPGD (0.46) HSD17B10TSHRSMN1; SMN2TDP1LMNA
SCHEMBL26164137 0.81 HPGD (0.46) HSD17B10TSHRSMN1; SMN2TDP1LMNA
SCHEMBL18554455 0.80 HPGD (0.47) HSD17B10TSHRTDP1LMNAL3MBTL1
SCHEMBL26164167 0.79 HSD17B10 (0.46) HSD17B10TSHRSMN1; SMN2MGAMGAA
SCHEMBL11617176 0.79 TDP1 (0.57) HSD17B10MGAMGAASIMGAM2
SCHEMBL29480852 0.77 TSHR (0.64) HSD17B10TSHRSMN1; SMN2MGAMGAA
SCHEMBL5734 0.77 TSHR (0.64) HSD17B10TSHRSMN1; SMN2MGAMGAA
SCHEMBL541391 0.77 TSHR (0.64) HSD17B10TSHRSMN1; SMN2TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP HSD17B10 1595/4885TSHR 3056/4885SMN1; SMN2 4063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.